商業用ジンセン製薬には何が含まれているのか.

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Journal of internal medicine·2017

Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms.

Neuroscience letters·2012

Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo.

Journal of internal medicine·2011

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

Journal of lipid research·2010

4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man.

International journal of clinical pharmacology and therapeutics·2009

Platelet alpha- and beta- secretase activities are not significantly affected by dementia or mild cognitive impairment in Swedish patients.

Current Alzheimer research·2009

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Revealing Griffithsin recognition of diverse virus-associated <i>N</i>-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Physical chemistry chemical physics : PCCP·2026

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Nature·2026

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Nature communications·2026

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

International journal of biological macromolecules·2026

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

International journal of biological macromolecules·2026

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

Vaccine·2026

関連する実験動画

商業用ジンセン製薬には何が含まれているのか.

関連する概念動画

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms.

Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo.

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man.

Platelet alpha- and beta- secretase activities are not significantly affected by dementia or mild cognitive impairment in Swedish patients.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Revealing Griffithsin recognition of diverse virus-associated <i>N</i>-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

関連する実験動画

商業用ジンセン製薬には何が含まれているのか.

関連する概念動画

関連記事